Speaker Details

Nada Elbuluk, MD, FAAD

Nada Elbuluk, MD, FAAD

SESSIONS

S030 Vitiligo
Mar 9, 2024 • 9:00 AM - 12:00 AM • Room 6C
U041 Pigmentary Potpourri: How to Evaluate, Diagnose, and Treat Pigmentary Conditions
Mar 9, 2024 • 4:30 PM - 12:00 AM • Room 30D
S060 Skin of Color
Mar 11, 2024 • 1:00 PM - 12:00 AM • Room 6B
F117 Where do We Stand? The Pathogenesis and Treatment of Melasma
Mar 11, 2024 • 3:30 PM - 12:00 AM • Room 6D

HANDOUTS

Login to view handouts

DISCLOSURES

AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Advisory Board(Fees); L'Oreal USA Inc. – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); SkinCeuticals LLC – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Teva Pharmaceuticals USA – Consultant (1099 relationship)(Fees); The Skin of Color Society – Board of Directors(No Compensation Received); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VisualDx – Consultant(Stock Options);